Search Results for "En Vivo EVP6124 Alzheimer"

22:55 EDT 15th September 2014 | BioPortfolio

Matching Channels

Cytoplasmic Protein Tau

One of the main pillars of current drug discovery and development activities in the pharmaceutical industry for Alzheimer's disease is prevention of the accumulation of misfolded proteins, i.e. ...

Histone Deacetylase HDAC Inhibitors

Histone deacetylase (HDAC) inhibitors are emerging as a new class of potential anticancer agents for the treatment of solid and hematological malignancies. HDAC inhibition causes acetylated nuclear ...

Nerve growth factor NGF

Nerve growth factor (NGF) is the prototypical member of the family of neurotrophin growth factors that are involved in the growth and survival of nervous tissue. NGF and its receptors, the tyrosine-...

Interleukin 1 IL 1 Receptor IL 1R

Interleukin-1 (IL-1) beta is a proinflammatory cytokine driving joint inflammation as well as systemic signs of inflammation, such as fever and acute phase protein production. Current therapy targetin...

Selective monoamine oxidase type B MAOB inhibitors

The clinical benefit of monoamine oxidase type B (MAO-B) inhibitors is thought to arise from an ability of these medications to enhance the level of dopamine by decreasing the catabolism. Additional...

Matching News

We Are A Long Way From An Alzheimer’s Cure

Two take-aways from the recently concluded Alzheimer’s Association Conference in Copenhagen: First, after years of research, we still know remarkably little about what causes dementia or how to prev...

Alzheimer’s Research U.K. calls for increased investment in Alzheimer’s drug trials

Alzheimer’s Research U.K. calls for increased investment in Alzheimer’s drug trials after a comprehensive study of all of the clinical trials for Alzheimer’s drugs in the U.S. highlighted a very...

Alzheimer’s Association offers Research Grant Program

The Alzheimer’s Association offers the Part the Cloud Translational Research Grant Program, which aims to fill the gap in Alzheimer’s disease drug development. The program supports early phase stu...

Marijuana Compound May Slow, Halt Alzheimer’s

Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the U...

National Alliance for Caregiving and Alzheimer’s Foundation of America Release Joint Report to Help States Implement Alzheimer’s Plans

New York, New York (PRWEB) July 23, 2014 In an effort to help advance the goals of the “National Plan to Address Alzheimer’s Disease” at the state level, the National Alliance for C...

Novartis forciert Alzheimer-Forschung

Basel - Der Pharma-Konzern Novartis will die Forschung und Entwicklung (F&E) zur Vorbeugung gegen die Alzheimer-Erkrankung forcieren. Alzheimer gilt als eine der künftig wichtigeren Therapien, die...

New Approach to Funding Alzheimer’s Research Could Pay Off

More than 5 million Americans suffer from Alzheimer’s disease, the affliction that erodes memory and other mental capacities, but no drugs targeting the disease have been approved by the U.S. Food a...

Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver

Denver, CO (PRWEB) July 24, 2014 This year the Walk to End Alzheimer’s in Denver , sponsored by E Light Electric and Jackson National Life, will be held on Saturday, September 20 in Denver Ci...

Matching PubMed Articles

Reelin Signaling Pathway Genotypes and Alzheimer Disease in a Spanish Population.

Several reports suggest that the reelin protein could play a role in Alzheimer pathophysiology. This led us to ask whether genetic variability in the reelin pathway may increase the risk of developing...

BP Variability and Cognitive Impairment: Vascular Risk Factors for Alzheimer Disease?

Rretraction notice to ‘‘1h-MRS can monitor metabolites changes of lateral intraventricular BDNF infusion into a mouse model of Alzheimer’s disease in vivo’’ Neuroscience 245 (2013) 40–49.

Simple method for evaluation of planum temporale pyramidal neurons shrinkage in postmortem tissue of Alzheimer disease patients.

We measured the length of the pyramidal neurons in the cortical layer III in four subregions of the planum temporale (transitions into superior temporal gyrus, Heschl's gyrus, insular cortex, and Sylv...

Alzheimer disease: An interactome of many diseases.

Alzheimer Disease (AD) is an outcome as well as source of many diseases. Alzheimer is linked with many other diseases like Diabetes type 2, cholesterolemia, hypertension and many more. But how each of...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement